Accuracy of a portable international normalization ratio monitor in outpatients receiving long-term oral anticoagulant therapy: Comparison with a laboratory reference standard using clinically relevant criteria for agreement

被引:75
作者
Douketis, JD
Lane, A
Milne, J
Ginsberg, JS
机构
[1] St Josephs Hosp, Hamilton, ON L8N 4A6, Canada
[2] McMaster Univ, Dept Med, Hamilton, ON, Canada
[3] Boehringer Mannheim Canada, Laval, PQ, Canada
关键词
oral anticoagulants; decentralized testing; prothrombin time; capillary blood;
D O I
10.1016/S0049-3848(98)00098-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The accuracy of a new, portable INR monitor (CoaguChek, Boehringer-Mannheim, Indianapolis, IN) was evaluated by comparing INR results from the portable monitor with results obtained by a laboratory-based method. Dual INR measurements (portable monitor, laboratory) were performed in 163 consecutive outpatients receiving warfarin. Agreement in dual INR measurements was defined based on clinically-relevant expanded and narrow criteria and statistical criteria. Agreement in dual INR measurements also was evaluated as a function of increasing INR. The proportion of dual INR measurements that satisfied the clinically-relevant expanded, and narrow agree ment criteria was 90%, and 86%, respectively. Seventy-nine percent of all dual measurements were within 0.5 INR units. The accuracy of the portable monitor was greatest for INR values less than 3.0; above this INR level, the portable monitor underestimated laboratory INR values. The proportion of dual INR measurements within 0.5 INR units for laboratory INR ranges of <2.0, 2.0-3.0, 3.1-4.0, and >4.0 was 98%, 87%, 57%, and 21%, respectively. We conclude that the portable INR monitor achieved a clinically acceptable level of accuracy when compared to the traditional laboratory method and provides a suitable alternative method of monitoring the INR in patients receiving warfarin. (C) 1998 Elsevier Science Ltd.
引用
收藏
页码:11 / 17
页数:7
相关论文
共 28 条
[1]   EVALUATION OF A PORTABLE PROTHROMBIN TIME MONITOR FOR HOME-USE BY PATIENTS WHO REQUIRE LONG-TERM ORAL ANTICOAGULANT-THERAPY [J].
ANDERSON, DR ;
HARRISON, L ;
HIRSH, J .
ARCHIVES OF INTERNAL MEDICINE, 1993, 153 (12) :1441-1447
[2]   PATIENT SELF-MANAGEMENT OF ORAL ANTICOAGULATION GUIDED BY CAPILLARY (FINGERSTICK) WHOLE-BLOOD PROTHROMBIN TIMES [J].
ANSELL, J ;
HOLDEN, A ;
KNAPIC, N .
ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (11) :2509-2511
[3]   COST-EFFECTIVENESS OF MONITORING WARFARIN THERAPY USING STANDARD VERSUS CAPILLARY PROTHROMBIN TIMES [J].
ANSELL, JE ;
HAMKE, AK ;
HOLDEN, A ;
KNAPIC, N .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1989, 91 (05) :587-589
[4]   ORAL ANTICOAGULANT-THERAPY - 50 YEARS LATER [J].
ANSELL, JE .
ARCHIVES OF INTERNAL MEDICINE, 1993, 153 (05) :586-596
[5]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[6]   OPTIMAL ORAL ANTICOAGULANT-THERAPY IN PATIENTS WITH MECHANICAL HEART-VALVES [J].
CANNEGIETER, SC ;
ROSENDAAL, FR ;
WINTZEN, AR ;
VANDERMEER, FJM ;
VANDENBROUCKE, JP ;
BRIET, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (01) :11-17
[7]   RISK-FACTORS FOR COMPLICATIONS OF CHRONIC ANTICOAGULATION - A MULTICENTER STUDY [J].
FIHN, SD ;
MCDONELL, M ;
MARTIN, D ;
HENIKOFF, J ;
VERMES, D ;
KENT, D ;
WHITE, RH .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (07) :511-520
[8]  
Fuster V, 1997, LANCET, V350, P389
[9]  
HYERS TM, 1995, CHEST S, V108, P335
[10]   RISK-FACTORS FAR INTRACRANIAL HEMORRHAGE IN OUTPATIENTS TAKING WARFARIN [J].
HYLEK, EM ;
SINGER, DE .
ANNALS OF INTERNAL MEDICINE, 1994, 120 (11) :897-902